Article Details

MaxCyte Signs Clinical and Commercial License with Sana Biotechnology

Retrieved on: 2021-08-09 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

MaxCyte Signs Clinical and Commercial License with Sana Biotechnology. View article details on hiswai:

Excerpt

(Nasdaq: SANA), a company focused on creating and delivering engineered cells as medicines. Under the terms of the agreement, Sana Biotechnology ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up